Kirin Acquires Jamieson Wellness for C$2.5bn, Expands North American VDS Footprint
Kirin Holdings has acquired Jamieson Wellness for C$2.5 billion, making the Canadian VDS leader a wholly-owned subsidiary. This move consolidates Kirin's preventative health strategy, establishing a significant North American platform to complement its existing Asia-Pacific portfolio.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Toronto, Canada — 06 August 2026
Kirin Holdings has confirmed its acquisition of Jamieson Wellness Inc., Canada's leading supplement company, for C$2.5 billion (US$1.78 billion). This transaction, expected to close in Q4 2026 pending regulatory and shareholder approvals, positions Kirin to accelerate its Health Science business expansion into the North American market, deemed the world's largest vitamins and dietary supplements (VDS) sector. The acquisition builds on Kirin's prior strategic moves, including the 2023 purchase of Blackmores and the 2024 acquisition of FANCL, establishing a preventative health platform spanning Asia, Oceania, and now North America.
Jamieson Wellness brings a 104-year heritage, established brands, extensive distribution networks, and integrated R&D, manufacturing, and sales capabilities. In its Q2 2026 results, Jamieson reported a 17.4% increase in consolidated revenue to C$233.8 million. Growth was notably strong in the US, up 21.7% on a constant currency basis to C$50.1 million, and in China, which saw a 46.6% increase to C$54.3 million. This performance underscores the strategic value Jamieson's market penetration offers Kirin, aligning with Kirin's long-term vision to achieve C$1.95 billion (300 billion yen) in health science revenue by 2030.
Kirin's COO, Takeshi Minakata, highlighted the acquisition as a critical milestone for expanding into North America. Alastair Symington, CEO of Blackmores Limited, further emphasised that Jamieson's trusted brands, innovation capabilities, and scalable platform will strengthen a global network connecting key VDS markets. The all-cash transaction will result in Jamieson Wellness operating as a wholly-owned subsidiary, with Kirin committing to invest in the Canadian brand's future growth while leveraging its own expertise in fermentation and biotechnology.
What this means for Canada
Canadian manufacturers and brand owners face a significant competitive shift. Kirin's capital injection and global network will likely boost Jamieson's market share further, potentially increasing shelf-space competition and pricing pressures. Brands should anticipate intensified marketing and innovation from the combined entity. Regulatory teams should monitor how Kirin integrates Jamieson's operations, particularly regarding ingredient sourcing and manufacturing compliance under Health Canada guidelines. Opportunities may arise for contract manufacturers aligned with Kirin's supply chain standards, or for smaller brands positioning themselves for niche markets not directly targeted by the new powerhouse.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.